Location History:
- Marseilles Cedex, FR (2014)
- Marseilles, FR (2015)
- Marseille Cedex, FR (2015)
Company Filing History:
3 out of 1,743 
3 out of 5,076 
2 out of 11 
Years Active: 2014-2015
Title: The Innovations of Jean-Pierre Gorvel
Introduction
Jean-Pierre Gorvel is a notable inventor based in Marseille, France. He has made significant contributions to the field of immunology through his innovative patents. With a total of three patents to his name, Gorvel's work focuses on enhancing vaccine efficacy and immune response.
Latest Patents
Gorvel's latest patents include "Immunoadjuvant compounds and uses thereof," which describes cyclic beta glucan compounds that function as immunoadjuvants. These compounds can be administered prior to, concurrently with, or after the administration of antigens to a subject. They are designed to activate dendritic cells, thereby enhancing the immune response. Another significant patent is for "Modified gram-negative bacteria for use as vaccines." This invention involves Gram-negative bacteria with an inactivated gene that alters the synthesis of lipopolysaccharides (LPS). These modified strains exhibit reduced virulence while still inducing sufficient humoral immunity for effective vaccination.
Career Highlights
Throughout his career, Gorvel has worked with prestigious institutions such as the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. His research has been pivotal in advancing vaccine technology and immunological research.
Collaborations
Gorvel has collaborated with notable colleagues, including Vilma Arce Gorvel and Maite Iriarte. Their joint efforts have contributed to the development of innovative solutions in the field of immunology.
Conclusion
Jean-Pierre Gorvel's contributions to immunology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence vaccine development and immune response enhancement.